4SCAR19

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 4SCAR19, covering 2025-09-08 to 2025-09-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies [Phase 1, Phase 2]

See pricing